Package Leaflet: Information for the User
Fluconazol Kabi 2mg/ml solution for infusion EFG
Fluconazole
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information:
Fluconazol Kabi is one of a group of medicines called “antifungals”. The active substance is fluconazole.
Fluconazol Kabi is used to treat infections caused by fungi and can also be used to prevent fungal infections from occurring. The most common cause of fungal infections is a yeast called Candida.
Adults
Your doctor may prescribe this medicine to treat the following types of fungal infections:
They may also prescribe Fluconazol Kabi for:
Children and adolescents (0 to 17 years)
Your doctor may prescribe this medicine to treat the following types of fungal infections:
They may also give you Fluconazol Kabi for:
Do not use Fluconazol Kabi
Warnings and precautions
Tell your doctor, pharmacist or nurse before you start taking Fluconazol Kabi
Severe skin reactions, including a drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with fluconazole treatment. Stop using Fluconazol Kabi and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Using Fluconazol Kabi with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Tell your doctor immediatelyif you are taking astemizole, terfenadine (an antihistamine for treating allergies), cisapride (used for stomach upset), pimozide (used for treating mental illness), quinidine (used for treating irregular heartbeats) or erythromycin (an antibiotic for treating infections), as these medicines must not be taken with Fluconazol Kabi (see section: “Do not use Fluconazol Kabi”).
There are some medicines that may interact with Fluconazol Kabi. Make sure your doctor knows if you are taking any of the following medicines, as it may be necessary to adjust the dose or monitor to check that the medicines are still working as intended:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
If you are planning to become pregnant, it is recommended that you wait one week after a single dose of fluconazole before becoming pregnant.
For longer treatment cycles with fluconazole, consult your doctor about the need to use adequate contraceptive methods during treatment, which should be continued for one week after the last dose.
Do not take Fluconazol Kabi if you are pregnant, think you may be pregnant, are trying to become pregnant or are breastfeeding, unless your doctor has told you to.
If you become pregnant while taking this medicine or within 1 week of the last dose, tell your doctor.
Fluconazole taken during the first or second trimester of pregnancy may increase the risk of miscarriage. Fluconazole taken during the first trimester may increase the risk of the baby being born with birth defects affecting the heart, bones and/or muscles.
There have been reports of babies born with congenital anomalies affecting the skull, ears and bones of the thigh and elbow in women treated for three months or more with high doses (400-800 mg daily) of fluconazole for coccidioidomycosis. The relationship between fluconazole and these cases is unclear.
You can continue breastfeeding after taking a single dose of up to 150 mg of Fluconazol Kabi.
Do not continue breastfeeding if you are taking repeated doses of Fluconazol Kabi.
Driving and using machines
When driving vehicles or operating machines, keep in mind that dizziness or seizures may occasionally occur.
Fluconazol Kabi contains sodium
This medicine contains 88.5 mg of sodium (main component of table/cooking salt) per 25 ml. This is equivalent to 4.4% of the maximum recommended daily intake of sodium for an adult.
Ask your doctor or pharmacist if you need Fluconazol Kabi daily for a prolonged period, especially if you have been advised to follow a low-salt diet.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Your doctor or nurse will give you this medicine by slow injection (infusion) directly into your vein. Fluconazol Kabi is supplied as a solution. It does not need to be diluted. Further information is provided at the end of this leaflet for healthcare professionals.
The following are the recommended doses of this medicine for the different types of infections. Check with your doctor or nurse if you are unsure whether you should receive treatment with Fluconazol Kabi.
Adults
Dose | Condition |
400 mg on the first day and then 200 mg to 400 mg once daily for 6 to 8 weeks or longer if necessary. The dose may be increased up to 800 mg. | For treating cryptococcal meningitis |
200 mg once daily until your doctor tells you | For preventing the recurrence of cryptococcal meningitis |
200 mg to 400 mg once daily from 11 months to 24 months or longer if necessary. The dose may be increased up to 800 mg. | For treating coccidioidomycosis |
800 mg on the first day and then 400 mg once daily until your doctor tells you | For treating internal fungal infections caused by Candida |
200 mg to 400 mg on the first day and then 100 mg to 200 mg until your doctor tells you | For treating mucosal infections that affect the lining of the mouth, throat or associated with dental prostheses |
50 mg to 400 mg once daily for 7 to 30 days until your doctor tells you | For treating mucosal candidiasis – the dose depends on the location of the infection |
100 mg to 200 mg once daily, or 200 mg 3 times a week, while the risk of developing an infection continues | For preventing the recurrence of mucosal infections that affect the lining of the mouth and throat |
200 mg to 400 mg once daily while the risk of developing an infection continues | For preventing the development of a Candida infection (if your immune system is weak and not working properly) |
Adolescents 12 to 17 years of age
Follow the dose prescribed by your doctor (adult or child posology).
Children up to 11 years
The maximum daily dose for children is 400 mg per day.
The dose will be based on the child's weight in kilograms.
Condition | Daily dose |
Mucosal candidiasis and throat infections caused by Candida– the dose and duration of treatment depend on the severity of the infection and its location. | 3 mg per kg of body weight once daily (on the first day, 6 mg per kg of body weight may be given) |
Cryptococcal meningitis or internal fungal infections caused by Candida | 6 mg to 12 mg per kg of body weight once daily |
For preventing the recurrence of cryptococcal meningitis | 6 mg per kg of body weight once daily |
For preventing the child from getting a Candida infection (if their immune system is not working properly) | 3 mg to 12 mg per kg of body weight |
Use in infants 0 to 4 weeks of age
Infants between 15 and 27 days of age:
? The same dose as described in the table, but given every 2 days. The maximum dose is 12 mg per kg of body weight every 48 hours.
Infants between 0 and 14 days of age:
? The same dose as described in the table, but given every 3 days. The maximum daily dose is 12 mg per kg of body weight every 72 hours.
Sometimes, doctors may prescribe different doses than those described. Follow your doctor's instructions exactly. Ask your doctor or pharmacist if you have any doubts.
Elderly patients
The usual adult dose, unless you have kidney problems.
Patients with kidney problems
Your doctor may change your dose, depending on how well your kidneys are working.
If you receive more Fluconazol Kabi than you should
If you are worried that you may have been given too much Fluconazol Kabi, tell your doctor or nurse immediately. Symptoms of a possible overdose may include hearing, seeing, feeling and thinking things that are not real (hallucinations and paranoid behavior).
If you miss a dose of Fluconazol Kabi
Since this medicine will be given under close medical supervision, it is unlikely that a dose will be missed. However, if you think that a dose may have been missed, talk to your doctor or pharmacist.
If you have any further questions on the use of this product, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Some people develop allergic reactions, although severe allergic reactions are rare.If some of the following symptoms appear, tell your doctor immediately.
Common Adverse Effects(may affect up to 1 in 10 people):
Uncommon Adverse Effects(may affect up to 1 in 100 people):
Rare Adverse Effects(may affect up to 1 in 1,000 people):
If you experience any of these symptoms, stop using Fluconazol Kabi and tell your doctor immediately.
Fluconazol Kabi may affect your liver. Signs that indicate liver problems include:
Common Adverse Effects(may affect up to 1 in 10 people):
Uncommon Adverse Effects(may affect up to 1 in 100 people):
Fluconazol Kabi may also affect other organs, which can lead to the following symptoms:
Uncommon Adverse Effects(may affect up to 1 in 100 people):
Rare Adverse Effects(may affect up to 1 in 1,000 people):
If you experience any of these symptoms, stop using Fluconazol Kabi and tell your doctor immediately.
Other Adverse Effects:
Additionally, if you consider that any of the adverse effects you are suffering from is serious or if you notice any adverse effect not mentioned in this leaflet, inform your doctor or pharmacist.
Common Adverse Effects (may affect up to 1 in 10 people):
Uncommon Adverse Effects (may affect up to 1 in 100 people):
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Frequency not known (cannot be estimated from available data):
Stop using Fluconazol Kabi and seek medical attention immediately if you notice any of the following symptoms:
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or nurse, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date indicated on the packaging after CAD. The expiration date is the last day of the month indicated.
Bags (freeflex®): Do not store above 25°C. Do not freeze.
Vials (KabiPac®): Do not freeze.
The medicine should be used immediately after opening the packaging.
Do not use this medicine if you notice that the solution is not transparent or if you notice visible particles. Do not use if the packaging shows visible signs of deterioration.
This medicine is for single use. After use, discard the vial or bag and any remaining contents.
Medicines should not be thrown away through wastewater or household waste. Ask your pharmacist how to dispose of packaging and medicines that are no longer needed. This will help protect the environment.
Composition of Fluconazol Kabi
The active ingredient is fluconazole.
Each ml of solution contains 2 mg of fluconazole.
The other components are: sodium chloride, water for injectable preparations and sodium hydroxide (to adjust the pH).
Appearance of the Product and Package Contents
1, 10, 20, 25, 30, 40, 50, 60 vials/bags of 50 ml containing 100 mg of fluconazole
1, 10, 20, 25, 30, 40, 50, 60 vials/bags of 100 ml containing 200 mg of fluconazole
1, 10, 20, 25, 30, 40 vials/bags of 200 ml containing 400 mg of fluconazole.
Not all formats may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Fresenius Kabi España S.A.U.
c/ Marina 16-18,
08005 Barcelona
Spain
Manufacturer
Vials (KabiPac®):
Fresenius Kabi Polska Sp. Zo.o
Ul. Sienkiewicza 25, 99-300 Kutno
Poland
Bags (Freeflex®):
Fresenius Kabi France
6, Rue de Rempart
F-27400 Louviers
France
This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
BelgiumFluconazole Fresenius Kabi 2mg/ml oplossing voor infusie
Czech RepublicFluconazol Kabi
DenmarkFluconazol Fresenius Kabi
FinlandFluconazol Fresenius Kabi
FranceFluconazole Kabi 2mg/ml
GermanyFluconazol Kabi 2mg/ml Infusionslösung
GreeceFluconazole/Kabi 2mg/ml δι?λυμα για ?γχυση
HungaryFluconazol Kabi
ItalyFluconazolo Kabi
LuxembourgFluconazol Kabi 2mg/ml Infusionslösung
MaltaFluconazole Kabi 2mg/ml solution for infusion
NetherlandsFluconazole Fresenius Kabi 2mg/ml oplossing voor infusie
PolandFluconazol Kabi
PortugalFluconazol Kabi
RomaniaFluconazol Kabi 2mg/ml solutie perfuzabila
SlovakiaFluconazol Kabi 2mg/ml, infúzny roztok
SpainFluconazol Kabi 2 mg/ml solución para perfusión
SwedenFluconazol Fresenius Kabi
United Kingdom
(Northern Ireland)Fluconazole 2mg/ml solution for infusion
Date of the last revision of this leaflet:February 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The following information is intended only for healthcare professionals:
Intravenous infusion should be administered at a rate not exceeding 10 ml/min.
Fluconazol Kabi is formulated with a 9 mg/ml (0.9%) sodium chloride solution for infusion. Each 200 mg (100 ml vial) contains 15 mmol of Na+ and also Cl-. Since Fluconazol Kabi is available in a diluted sodium chloride solution, in patients with sodium or fluid restriction, the fluid administration rate should be taken into account.
Fluconazol is compatible with the following solutions:
Fluconazol can be infused through an existing line along with any of the fluids listed above. Although no specific incompatibilities have been described, it is not recommended to mix Fluconazol Kabi with other medicines before infusion.
The infusion solution is for single use.
The physical-chemical stability of the diluted product has been demonstrated for 24 hours at 25°C.
From a microbiological point of view, dilutions should be used immediately. If not used immediately, the storage times and conditions before use are the responsibility of the user and normally should not exceed 24 hours at 2-8°C, unless the dilution has been made in validated aseptic conditions.
Dilution should be performed in aseptic conditions. Before administration, the solution should be inspected to check for visible particles or discoloration. The solution should only be used if it is transparent and free of particles.
Disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for FLUCONAZOLE KABI 2 mg/ml SOLUTION FOR INFUSION – subject to medical assessment and local rules.